UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
PUT
Union Pacific
UNP
$166B
| $9.87M | ﹤0.01% |
36,300
-160,100
| -82% | -$42M |
|
3452
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $9.87M | ﹤0.01% |
296,755
-81,968
| -22% | -$2.56M |
|
3453
Invesco Municipal Opportunity Trust
VMO
$623M
| $9.86M | ﹤0.01% |
999,416
-64,554
| -6% | -$626K |
|
3454
Dyne Therapeutics
DYN
$3.2B
| $9.85M | ﹤0.01% |
443,284
+62,723
| +16% | +$1.17M |
|
3455
Westlake Chemical Partners
WLKP
$748M
| $9.84M | ﹤0.01% |
442,165
-15,562
| -3% | -$355K |
|
3456
COPT Defense Properties
CDP
$3.9B
| $9.84M | ﹤0.01% |
270,287
+43,782
| +19% | +$1.42M |
|
3457
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$580M
| $9.83M | ﹤0.01% |
196,066
-7,089
| -3% | -$334K |
|
3458
M/I Homes
MHO
$3.51B
| $9.83M | ﹤0.01% |
61,149
+11,799
| +24% | +$1.58M |
|
3459
Azenta
AZTA
$1.46B
| $9.83M | ﹤0.01% |
385,166
-183,929
| -32% | -$4.12M |
|
3460
ADMA Biologics
ADMA
$2.04B
| $9.82M | ﹤0.01% |
1,173,033
-977,243
| -45% | -$8.91M |
|
3461
DoubleVerify
DV
$2.09B
| $9.81M | ﹤0.01% |
905,436
+63,536
| +8% | +$654K |
|
3462
CALL
Bristol-Myers Squibb
BMY
$129B
| $9.81M | ﹤0.01% |
170,300
-133,000
| -44% | -$7.64M |
|
3463
Prudential
PUK
$32.2B
| $9.81M | ﹤0.01% |
366,008
+298,080
| +439% | +$8.7M |
|
3464
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.38B
| $9.81M | ﹤0.01% |
302,844
+293,146
| +3,023% | +$34.9M |
|
|
VGNT
3465
Versigent PLC
VGNT
$3.25B
| $9.81M | ﹤0.01% |
233,564
+232,070
| +15,533% | +$9.25M |
|
3466
PUT
Boston Scientific
BSX
$62.8B
| $9.8M | ﹤0.01% |
229,600
-30,100
| -12% | -$1.63M |
|
|
OGC
3467
OceanaGold Corp
OGC
$6.33B
| $9.8M | ﹤0.01% |
+390,716
| New | +$11.7M |
|
3468
CVR Energy
CVI
$5.4B
| $9.8M | ﹤0.01% |
355,747
+2,010
| +0.6% | +$63.8K |
|
3469
Nuveen Multi-Asset Income Fund
NMAI
$471M
| $9.79M | ﹤0.01% |
690,881
+19,527
| +3% | +$268K |
|
3470
STAAR Surgical
STAA
$1.04B
| $9.79M | ﹤0.01% |
341,183
+161,254
| +90% | +$4.48M |
|
3471
Sprott Uranium Miners ETF
URNM
$1.91B
| $9.78M | ﹤0.01% |
185,945
+3,035
| +2% | +$188K |
|
3472
Procept Biorobotics
PRCT
$1.11B
| $9.78M | ﹤0.01% |
432,993
-71,500
| -14% | -$1.79M |
|
3473
iShares MSCI Hong Kong ETF
EWH
$1.16B
| $9.76M | ﹤0.01% |
466,455
+316,853
| +212% | +$7.29M |
|
3474
Mineralys Therapeutics
MLYS
$2.48B
| $9.76M | ﹤0.01% |
361,596
+263,567
| +269% | +$7.23M |
|
3475
CALL
QuantumScape Corp
QS
$3.09B
| $9.74M | ﹤0.01% |
1,288,500
+876,000
| +212% | +$6.57M |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.